ORCID as entered in ROS
![orcid_icon](/themes/resgate8/images/icons/ORCIDiD_icon24x24.png)
Select Publications
2008, 'Cardiac alpha(1)-adrenergic drive in pathological remodelling', Cardiovascular Research, 77, pp. 452 - 462, http://dx.doi.org/10.1093/cvr/cvm078
,2008, 'Endothelial progenitor cells, angioblasts, and angiogenesis - Old terms reconsidered from a current perspective', Trends in Cardiovascular Medicine, 18, pp. 45 - 51
,2008, 'Heightened alpha(1A)-adrenergic receptor activity suppresses ischaemia/reperfusion-induced Ins(1,4,5)P-3 generation in the mouse heart: a comparison with ischaemic preconditioning', Clinical Science, 114, pp. 157 - 164, http://dx.doi.org/10.1042/C20070110
,2008, 'Reproducibility of Adenosine Stress Cardiac Magnetic Resonance Imaging by Normalised Upslope Analysis in Patients with Severe Coronary Artery Disease', Heart, Lung and Circulation, 17, pp. S47 - S48, http://dx.doi.org/10.1016/j.hlc.2008.05.109
,2008, 'Safety and efficacy of consecutive cycles of granulocyte-colony stimulating factor, and an intracoronary CD 133(+) cell infusion in patients with chronic refractory ischemic heart disease: The G-CSF in Angina patients with IHD to stimulate Neovascul', American Heart Journal, 156, pp. 954 - 963
,2008, 'Wide turn diversity in protein transmembrane helices implications for G-protein-coupled receptor and other polytopic membrane protein structure and function', Molecular Pharmacology, 73, pp. 1092 - 1104, http://dx.doi.org/10.1124/mol.107.043042
,2007, 'Abstract 2669: The Use of Granulocyte-Colony Stimulating Factor in Angina Patients to Stimulate Neovascularization: the GAIN I study', Circulation, 116, http://dx.doi.org/10.1161/circ.116.suppl_16.ii_591-d
,2007, 'Altered sensation [1]', British Dental Journal, 203, pp. 227, http://dx.doi.org/10.1038/bdj.2007.795
,2007, 'Access to the chin [10]', British Dental Journal, 202, pp. 645, http://dx.doi.org/10.1038/bdj.2007.490
,2007, 'Actions and therapeutic potential of G-CSF and GM-CSF in cardiovascular disease', Journal of Molecular and Cellular Cardiology, 42, pp. 19 - 33
,2007, 'Bacterially derived 400 nm particles for encapsulation and cancer cell targeting of chemotherapeutics', Cancer Cell, 11, pp. 431 - 445
,2007, 'Phenotypic characterization of CD133+cells suggests a potent hemangioblast population', Circulation Research, 101, pp. E55 - E56
,2007, 'Profound thrombocytopenia related to G-CSF', American Journal of Hematology, 82, pp. 229 - 230
,2007, 'Recombinant Human Neuregulin-1 (rhNRG-1) Improves Cardiac Output in Patients with Stable Chronic Heart Failure', Heart, Lung and Circulation, 16, pp. S13 - S13, http://dx.doi.org/10.1016/j.hlc.2007.06.034
,2007, 'Store-Operated Ca2+ Influx and Expression of TRPC Genes in Mouse Sinoatrial Node', Circulation Research, 100 (11), pp. 1605 - 1614
,2007, 'Transglutaminase 2 regulates mallory body inclusion formation and injury-associated liver enlargement', Gastroenterology, 132, pp. 1515 - 1526
,2006, 'ABCA12 is the major harlequin ichthyosis gene', Journal of Investigative Dermatology, 126, pp. 2408 - 2413, http://dx.doi.org/10.1038/sj.jid.5700455
,2006, 'Mutation of a critical arginine in the GTP-binding site of transglutaminase 2 disinhibits intracellular cross-linking activity', JOURNAL OF BIOLOGICAL CHEMISTRY, 281, pp. 12603 - 12609, http://dx.doi.org/10.1074/jbc.M600146200
,2006, 'The α
2006, 'Cardiac overexpression of the alpha(1A)-adrenergic receptor limits post-infarct ventricular remodeling and dysfunction, and improves survival', Journal of Molecular and Cellular Cardiology, 41, pp. 735 - 735
,2006, 'Cross-linking transglutaminases with G protein-coupled receptor signaling.', Science S Stke, 353, pp. pe34, http://dx.doi.org/10.1126/stke.3532006pe34
,2006, 'Mechanism of allosteric regulation of transglutaminase 2 by GTP', Proceedings of the National Academy of Sciences of the United States of America, 103, pp. 19683 - 19688
,2006, 'Mutation of a critical arginine in the GTP-binding site of transglutaminase 2 disinhibits intracellular cross-linking activity', The Journal of Biological Chemistry, 281, pp. 12603 - 12609, http://dx.doi.org/10.1074/jbc.M600146200
,2006, 'Neuregulin-1/erbB-activation improves cardiac function and survival in models of ischemic, dilated, and viral cardiomyopathy', Journal of the American College of Cardiology, 48, pp. 1438 - 1447
,2006, 'Sustained augmentation of cardiac alpha(1A)-adrenergic drive results in pathological remodeling with contractile dysfunction, progressive fibrosis and reactivation of matricellular protein genes', Journal of Molecular and Cellular Cardiology, 40, pp. 540 - 552
,2006, 'The alpha(1D)-adrenergic receptor: Cinderella or ugly stepsister', Molecular Pharmacology, 69, pp. 1 - 4
,2006, 'Transgenic alpha(1A)-adrenergic activation limits post-infarct ventricular remodeling and dysfunction and improves survival', Cardiovascular Research, 71, pp. 735 - 743
,2005, 'Granulocyte-Colony Stimulating Factor Decreases Angina and Improves Exercise Capacity in Patients with Chronic Refractory ‘No Option’ Ischemic Heart Disease.', Blood, 106, pp. 4215 - 4215, http://dx.doi.org/10.1182/blood.v106.11.4215.4215
,2005, 'Grant watch report: Leveraging the power of the media to combat HIV/AIDS: The Kaiser Family Foundation's partnerships with media and others to help educate the public about HIV/AIDS, here and abroad', Health Affairs, 24, pp. 854 - 857, http://dx.doi.org/10.1377/hlthaff.24.3.854
,2005, 'Are improvements in cardiac function due to stem cell uptake and engraftment?', American Journal of Cardiology, 95, pp. 159, http://dx.doi.org/10.1016/j.amjcard.2004.07.138
,2005, 'Naltrexone implants as treatment for heroin dependence: Part I (multiple letters)', Addiction Biology, 10, pp. 201, http://dx.doi.org/10.1080/13556210500155789
,2005, 'Allosteric inactivation of transglutaminase 2 by GTP involves stabilisation of a conformational substate and formation of a critical Cys/Tyr H-bond', Biophysical Journal, 88, pp. 15A - 15A
,2005, 'Allosteric regulation of the transamidase activity of transglutaminase 2 by guanine nucleotide', FEBS Journal, 272, pp. 408 - 408
,2005, 'Evolutionary origins of exopeptidase activity in the C-domain of human angiotensin I-converting enzyme', Federation of American Societies for Experimantal Biology Journal, 19, pp. A293 - A293
,2005, 'Granulocyte-colony stimulating factor decreases angina and improves exercise capacity in patients with chronic refractory `no option` ischemic heart disease', Blood, 106, pp. 134B - 134B
,2005, 'Molecular basis of exopeptidase activity in the C-terminal domain ofhuman angiotensin I-converting enzyme - Insights into the origins ofits exopeptidase activity', The Journal of Biological Chemistry, 280, pp. 6669 - 6675
,2005, 'Naltrexone implants as treatment for heroin dependence: Part II', Addiction Biology, 10, pp. 202 - 202
,2005, 'Transglutaminases in perspective', Journal of Neurochemistry, 94, pp. 82 - 82
,2005, 'Update on the use of stem cells for cardiac disease', Internal Medicine Journal, 35, pp. 348 - 356
,2004, 'Stem-cell therapy for myocardial diseases [4] (multiple letters)', Lancet, 363, pp. 1734 - 1735, http://dx.doi.org/10.1016/s0140-6736(04)16268-5
,2004, 'Cardiac myocyte intracellular calcium handling and contractility inalpha1(A)-adrenergic receptor overexpressing', Journal of Molecular and Cellular Cardiology, 37, pp. 301 - 301
,2004, 'Cardiac-restricted overexpression of the alpha(1A)-adrenergic receptor preserves contractile function and limits ventricular remodeling after myocardial infarction', Circulation, 110, pp. 300 - 300
,2004, 'Evaluation of Therapeutic Drug Monitoring Services and Comparison of Two Models of Service Provision', Journal of Pharmacy Practice and Research, 34, pp. 109 - 113
,2004, 'Genetic enhancement of ventricular contractility protects against pressure-overload-induced cardiac dysfunction', Journal of Molecular and Cellular Cardiology, 37, pp. 979 - 987
,2004, 'Involvement of chymase-mediated angiotensin II generation in blood pressure regulation', Journal of Clinical Investigation, 114, pp. 112 - 120
,2004, 'Phospholipase C-[delta]1 rescues intracellular Ca2+ overload in ischemic heart and hypoxic neonatal cardiomyocytes', Journal of Steroid Biochemistry and Molecular Biology, 91, pp. 131 - 138, http://www.sciencedirect.com/science/article/B6T8X-4CSYKH2-1/2/ddae75a5eacab1a819c826961b301a29
,2004, 'Stem-cell therapy for myocardial diseases', The Lancet, 363, pp. 1735 - 1736, http://www.sciencedirect.com/science/article/B6T1B-4CF51H5-16/2/5af11943dcf04c84ca831fb4b99586df
,2003, 'IGF-1 Enhances a Store-Operated Ca2+ Channel in Skeletal Muscle Myoblasts: Involvement of a CD20-Like Protein', Journal of Cellular Physiology, 197, pp. 53 - 60, http://dx.doi.org/10.1002/jcp.10347
,2003, 'Allosteric á1-adrenoceptor antagonism by the conopeptide ñ-TIA', The Journal of Biological Chemistry, 278, pp. 34451 - 34457, http://dx.doi.org/10.1074/jbc.M305410200
,2003, 'Cardiac-targeted overexpression of the α1A-AR results in premature death: A potential model of electromechanical dissociation', Heart, Lung and Circulation, 12, pp. A59 - A59, http://dx.doi.org/10.1046/j.1443-9506.2003.02393.x
,